Precocious Puberty: Understanding Causes, Symptoms & Prevalence
Precocious puberty (PP) = secondary sexual characteristics before age 8 in girls, 9 in boys. Incidence: 1:5,000–1:10,000; female:male ratio ~4:1.
Types
- Central (GnRH-dependent): premature HPG axis activation; idiopathic (90% girls), CNS lesions (tumors, hamartoma, post-radiation).
- Peripheral (GnRH-independent): autonomous sex steroid production (ovarian/testicular tumors, adrenal hyperplasia, exogenous hormones).
Trends
Secular decline in pubertal onset age over past decades; possible contributors: increased BMI, endocrine disruptors, psychosocial stress. True PP prevalence rising; requires distinction from benign variants (premature thelarche, adrenarche).
Evaluation
- Bone age (advanced).
- Basal/stimulated LH/FSH (GnRH agonist test).
- Pelvic/Adrenal MRI if central.
- Genetic testing (MKRN3, DLK1) emerging.
Treatment
GnRH analogs (leuprolide, triptorelin) for central PP: halt progression, preserve adult height, mitigate psychosocial impact.
Genetic Disorders - Related Articles
- Syndrome, Karyotype, and Pedigree: Definitions and Differences in Genetics
- Albinism Genotypes: Genetic Types and Inheritance Patterns
- Deep Vein Thrombosis Risk in Black Populations: Multifactorial Drivers & Mitigation
- DNA Extraction: Importance, Methods & Applications
- Cystic Fibrosis & Lung Transplantation: Understanding the Need
- End-of-Life Care for Down Syndrome with Dementia: A Compassionate Approach
- Tay-Sachs Disease Genotype: HEXA Mutations, Inheritance & Testing
